Drug Discovery World

AUGUST 24, 2023

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, ”, which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW.

Big Data 52

Big Data Drugs Genome Genomics 52

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

pharmaphorum

MAY 23, 2022

The results generated in the study will be combined with data from Tohoku’s Medical Megabank Project (TMM), a wide-ranging national project that is tracking the health of the Japanese population, originally set up in response to the 2011 earthquake and tsunami.

Big Data 90

Big Data Genome Genomics Development 90

pharmaphorum

SEPTEMBER 16, 2022

Essentially, the collaboration brought together both “the right expertise and the right technology”, opening up myriad possibilities for targeting GPCRs within the human genome. Verily’s Immune Profiler can, Kim asserted, “generate more than 8 million immune measures across 24 immune cell subsets”. What, then, is the solution?

Development 130

Development Research Drugs Clinical Trials 130

pharmaphorum

DECEMBER 14, 2020

The post 5th Microbiome Movement – Drug Development Summit Europe 2021 appeared first on.

Development 52

Development Drugs Big Data Genome 52

XTalks

APRIL 5, 2021

The Human Genome Project could not have succeeded without the use of bioinformatics. Specific skills are required to succeed in this job; these include advanced writing skills for scientific literature, developing software tools, working on genome sequencing projects, and designing DNA sequencing libraries.

Bioinformatics 59

Bioinformatics Engineer Scientist Genome 59

pharmaphorum

APRIL 8, 2022

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

Genome 58

Genome Genomics Research Big Data 58

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care. He holds an MS degree in Statistics and a BS-equivalent in Bioengineering.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

pharmaphorum

JUNE 15, 2021

Sitting at the center of the convergence between digital innovation, big data, and shifting stakeholder demands is the emerging trend of hospitals without walls, in which hospitals represent a digitally connected community rather than a circumscribed physical space. One catalyst for this has been the COVID?19

Big Data 52

Big Data Nurses Genome Genomics 52

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar.

Genome 104

Genome Genomics Research Medicine 104

Drug Discovery World

FEBRUARY 6, 2024

Verge Genomics’ potential amyotrophic lateral sclerosis (ALS) treatment VRG50635 is one of the first drugs to enter clinical trials that was entirely discovered and developed using an AI-enabled platform 6. “For Automation is also being applied to genomics sample preparation, an area that requires particular robustness and scalability.

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

DECEMBER 27, 2023

A deep dive into US drug discovery What lies in the future for genomics and big data?

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

Delveinsight

FEBRUARY 17, 2021

The collected data and the genomic studies can play a crucial role in monitoring the symptoms and predicting potential diseases. . The safety of patients’ data is always a vital issue in the healthcare industry. Cybersecurity in Healthcare.

Doctors 52

Doctors Doctor Big Data Development 52

The Pharma Data

JANUARY 4, 2021

Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Barber also serves on Kiromic’s Scientific Advisory Board. About Longwood University.

In-Vivo 40

In-Vivo Development Big Data Immune Response 40

pharmaphorum

DECEMBER 8, 2022

The advent of biologic therapies in the 1970s along with the decoding of the human genome in 2003 heralded an explosion in pharmaceutical innovation.

Big Data 75

Big Data Gene Therapy Medicine Marketing 75

pharmaphorum

SEPTEMBER 18, 2020

Meanwhile, the search for the ‘right target’ led the company to collaborate with Cancer Research UK and launch the Functional Genomics Centre , a centre of excellence for genetic screening, cancer modelling and big data processing aimed at accelerating the discovery of new cancer medicines, including those based on CRISPR technology.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

Drug Discovery World

AUGUST 9, 2023

Another area of research which is really exciting for the whole industry is genomics and genetically targeted medicines. We are beginning to see the impact of big data and AI, enabling us to move a bit faster through the development process, and also to be more targeted in our R&D. That’s key for us.

Drugs 52

Drugs Antibody Big Data Medicine 52

Drug Discovery World

SEPTEMBER 5, 2022

Genome interpretation: To decipher genetic variants in cancer . Current problem: Genetic variants identified using genomic sequencing belong to coding regions of the genome, leaving out the majority of cancer-associated variants that lie in the non-coding areas outside exons, comprising over 98% of the genome.

Development 52

Development Drugs Protein Genome 52

Drug Discovery World

SEPTEMBER 6, 2022

The use of big data and AL to direct the best patient candidates for CGT and to provide the best understanding of efficacy and benefits.” – ? Research into genomic medicines is only at its infancy. Chris Nowers, CEO, ONK Therapeutics. . “

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

Drug Discovery World

FEBRUARY 9, 2023

While the industry has benefited from that low hanging fruit, including high throughput screening and genomics, leading to substantial discoveries, there is more to be done. We are entrenched in the era of big data and are amassing an insurmountable quantity of human-derived data to better inform our efforts in finding treatments.

Drugs 52

Drugs Development Big Data Scientist 52

Drug Discovery World

NOVEMBER 18, 2022

And these peptides are encoded in the bacterial genome.? . Since the genes for peptide antibiotics share a similar characteristic, the teams could use computational analysis to screen the entire genome of bacteria that produced such peptides. . Keeping up to date with the latest research in?antimicrobials

Bacteria 52

Bacteria Drugs Development Research 52

Drug Discovery World

MAY 4, 2023

Big data handling and machine learning made progress by leaps. Networks also allow us to integrate diverse types of biological pathways, literature, genomics, transcriptomics, proteomics and ligand-binding studies. Combined with internet technologies, the progress in drug discovery has been phenomenal.

Medicine 52

Medicine Protein Drugs Bioassay 52

pharmaphorum

MARCH 16, 2021

“We’ve seen AI being used in a number of ways during the pandemic – from tracking genome mutations of COVID-19, to drug re-purposing and predictive models using machine learning for ICU and mortality rates. We’ve also seen some diagnostic AI tools for radiology distinguishing between pneumonia and COVID,” says Medrano.

Doctors 112

Doctors Doctor Life Science Clinical Research 112

pharmaphorum

FEBRUARY 17, 2022

Led by researchers from the University of Oxford ‘s Big Data Institute, the study underscores the significance of analysing viruses continually over time. BEEHIVE’s researchers opted to use whole-genome sequencing (WGS) to evaluate the virus’ transformations over time. The VB variant. About the author.

Genome 95

Genome Genomics Genetics Genotype 95

The Pharma Data

JANUARY 17, 2021

Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond. With the COVID-19 pandemic, there has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent” says Michael D. .

Life Science 52

Life Science Engineer Big Data Scientist 52